RIDGEFIELD, Conn., Oct. 23, 2017 /PRNewswire/ -- Boehringer Ingelheim announced today the presentation of a new analysis on the use of Ofev® (nintedanib) in treating people with idiopathic pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback